EA also regulates lipid metabolism by influencing the expression of genes involved in lipogenesis (SREBP-1c, FASN) and β-oxidation of fatty acids (PPARα, CPT1), which may be important in the prevention of MASLD. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.